Request Info


Ask for our annual reports or more information
Email Us

Email Alerts

Sign up for email alerts
Email Alerts
Investor Relations

SEC Filings

RSS RSS Feeds
Form 10-K
MERIDIAN BIOSCIENCE INC filed this Form 10-K on 11/29/2013
Document Outline
Entire Document (2891.3 KB)
Subdocument 1 - 10-K - 10-K
Page 1 - SECURITIES AND EXCHANGE COMMISSION
Page 2 - N/A
Page 3 - BUSINESS
Page 4 - Reportable Segments
Page 5 - C. difficile
Page 6 - Market Trends
Page 7 - EMEA
Page 8 - Helicobacter pylori
Page 9 - Manufacturing
Page 10 - Medical Device Tax
Page 11 - Market Trends
Page 12 - Competition
Page 13 - International Markets
Page 14 - We may be unable to successfully integrate operations or to achieve expected cost savings from acqui
Page 15 - Seasonal Factors and Sporadic Outbreaks
Page 16 - Revenues for our Life Science segment may be impacted by customer concentrations and buying patterns
Page 17 - Risks Affecting our Manufacturing Operations
Page 18 - We depend on sole-source suppliers for certain critical raw materials and components, and finished p
Page 19 - Risks Related to Intellectual Property and Product Liability
Page 20 - Other Risks Affecting Our Business
Page 21 - Risks Related to Our Common Stock
Page 22 - LEGAL PROCEEDINGS
Page 23 - SELECTED FINANCIAL DATA
Page 24 - Non-GAAP Information
Page 25 - REVENUE OVERVIEW
Page 26 - N/A
Page 27 - Revenue Overview- By Product Platform/Type
Page 28 - illumi
Page 29 - Diagnostic Revenue Overview- By Disease Family
Page 30 - Foreign Currency
Page 31 - Operating Expenses:
Page 32 - Fiscal 2013
Page 33 - Operating Income
Page 34 - Impact of Inflation
Page 35 - Capital Resources
Page 36 - Known Contractual Obligations:
Page 37 - Concentration of Customers/Products Risk
Page 38 - illumi
Page 39 - Inventories
Page 40 - Income Taxes
Page 41 - QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Page 42 - FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
Page 43 - Management s Report on Internal Control over Financial Reporting
Page 44 - REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Page 45 - N/A
Page 46 - CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except per share data)
Page 47 - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (dollars in thousands)
Page 48 - CONSOLIDATED STATEMENTS OF CASH FLOWS (dollars in thousands)
Page 49 - CONSOLIDATED BALANCE SHEETS (dollars in thousands)
Page 50 - CONSOLIDATED BALANCE SHEETS (dollars in thousands)
Page 51 - CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY (dollars and shares in thousands, except per share da
Page 52 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Page 53 - N/A
Page 54 - N/A
Page 55 - illumi
Page 56 - illumi
Page 57 - N/A
Page 58 - Presentation of Comprehensive Income
Page 59 - Comprehensive Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Compreh
Page 60 - (4) Fair Value Measurements
Page 61 - (5) Income Taxes
Page 62 - N/A
Page 63 - (6) Employee Benefits
Page 64 - N/A
Page 65 - N/A
Page 66 - N/A
Page 67 - (7) Reportable Segment and Major Concentrations Data
Page 68 - N/A
Page 69 - N/A
Page 70 - (8) Commitments and Contingencies
Page 71 - (9) Quarterly Financial Data (Unaudited)
Page 72 - CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS
Page 73 - EQUITY COMPENSATION INFORMATION
Page 74 - EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
Page 75 - N/A
Page 76 - N/A
Page 77 - Year Ended September 30, 2013:
Subdocument 2 - EX-10.8 - EX-10.8
Page 1 - Exhibit 10.8
Page 2 - FY 2013 Published Net Earnings Guidance Range Diluted EPS of $.******
Page 3 - N/A
Subdocument 3 - EX-10.10 - EX-10.10
Page 1 - Exhibit 10.10
Page 2 - 4. Payment.
Page 3 - 9. No Employment Contract.
Page 4 - 18. Successors and Assigns.
Page 5 - N/A
Subdocument 4 - EX-10.11 - EX-10.11
Page 1 - Exhibit 10.11
Page 2 - 3. Forfeiture of Restricted Units
Page 3 - 7. Dividend Equivalent Payment Rights
Page 4 - 15. Section 409A of the Code
Page 5 - 21. Language
Subdocument 5 - EX-13 - EX-13
Page 1 - Exhibit 13
Page 2 - CORPORATE PROFILE
Page 3 - Corporate Data
Page 4 - COMPARISON OF 5 YEAR CUMULATIVE TOTAL RETURN*
Subdocument 6 - EX-21 - EX-21
Page 1 - Exhibit 21
Subdocument 7 - EX-23 - EX-23
Page 1 - Exhibit 23
Subdocument 8 - EX-31.1 - EX-31.1
Page 1 - Exhibit 31.1
Subdocument 9 - EX-31.2 - EX-31.2
Page 1 - Exhibit 31.2
Subdocument 10 - EX-32 - EX-32
Page 1 - Exhibit 32
XBRL Item - EX-101.INS - XBRL INSTANCE DOCUMENT (What's this?)
XBRL Item - EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA (What's this?)
XBRL Item - EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE (What's this?)
XBRL Item - EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE (What's this?)
XBRL Item - EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE (What's this?)
XBRL Item - EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE (What's this?)
XBRL Viewer